Sustained lower rates of HRT prescribing and breast cancer incidence in Australia since 2003

Breast Cancer Research and Treatment

Volumn 117, Issue 3, 2009, Pages 671-673

  Canfell, Karen ^a,b   Banks, Emily ^c   Clements, Mark ^c   Kang, Yoon Jung ^a,b   Moa, Aye ^a   Armstrong, Bruce ^b   Beral, Valerie ^d  

^a CANCER RESEARCH DIVISION   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c The Australian National University   (Australia)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AUSTRALIA; BREAST CANCER; CANCER INCIDENCE; CANCER SCREENING; FEMALE; HORMONE SUBSTITUTION; HUMAN; LETTER; MAMMOGRAPHY; PRESCRIPTION; PRIORITY JOURNAL;

ADULT; AUSTRALIA; BREAST NEOPLASMS; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; INCIDENCE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PRESCRIPTIONS;

EID: 70349578382     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-009-0331-3     Document Type: Letter

References (8)

1. K Canfell E Banks AM Moa, et al. 2008 Decrease in breast cancer incidence following a rapid fall in use of hormone replacement therapy in Australia Med J Aust 188 641 644 18513172
2. Australian Institute of Health and Welfare BreastScreen Australia monitoring report 2004-2005. AIHW. Canberra, Australia 2008. Cancer series no. 42. Cat. no. CAN 37
3. PM Ravdin KA Cronin N Howlader, et al. 2007 The decrease in breast-cancer incidence in 2003 in the United States N Engl J Med 356 1670 1674 10.1056/NEJMsr070105 17442911 10.1056/NEJMsr070105 1:CAS:528: DC%2BD2sXksFCltL0%3D (Pubitemid 46631679)
4. Cronin KA, Ravdin PM, Edwards BK (2008) Sustained lower rates of breast cancer in the United States. Breast Cancer Res Treat. doi: 10.1007/s10549-008- 0226-8
5. M Kumle 2008 Declining breast cancer incidence and decreased HRT use Lancet 372 608 610 10.1016/S0140-6736(08)61255-6 18722851 10.1016/S0140-6736(08) 61255-6
6. Collaborative Group on Hormonal Factors in Breast Cancer 1997 Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52, 705 women with breast cancer and 108, 411 women without breast cancer Lancet 350 1047 1059 10.1016/S0140-6736(97)08233-0 10.1016/S0140-6736(97)08233-0 (Pubitemid 27437855)
7. Million Women Study Collaborators 2003 Breast cancer and hormone-replacement therapy in the million women study Lancet 362 419 427 10.1016/S0140-6736(03)14065-2 10.1016/S0140-6736(03)14065-2 (Pubitemid 36999703)
8. RT Chlebowski LH Kuller RL Prentice 2009 Breast cancer after use of estrogen plus progestin in postmenopausal women N Engl J Med 360 573 19196674 10.1056/NEJMoa0807684 1:CAS:528:DC%2BD1MXhsFyiur8%3D